We are thrilled to announce that TAmiRNA will participate in the SURGER-I Innsbruck Congress on December 12–13, 2024. This premier event brings together leading experts, researchers, and practitioners to explore advancements in hepatopancreatobiliary surgery and transplantation.
As a proud sponsor, we will showcase our hepatomiR® kit, the first CE-IVD microRNA biomarker for the pre-operative assessment of liver function. Attendees can find us featured in the final program and on an intermission slide during the event.
We are also delighted to share that Dr. Matthias Hackl, CEO/CSO of TAmiRNA, will be attending the conference. This provides an excellent opportunity to connect and learn about our latest clinical trial data, as well as how hepatomiR® can be implemented in clinical trials or routine diagnostics.
We look forward to engaging with the vibrant community at SURGER-I Innsbruck 2024. Stay tuned for updates, and feel free to contact us at info@tamirna.com to arrange a meeting or discussion during the event.
TAmiRNA CEO/CSO Dr. Matthias Hackl
